International guideline changes and the incidence of infective endocarditis: a systematic review

@article{Khan2016InternationalGC,
  title={International guideline changes and the incidence of infective endocarditis: a systematic review},
  author={O. Khan and A. Shafi and A. Timmis},
  journal={Open Heart},
  year={2016},
  volume={3}
}
The objective of this study was to determine the impact on incident infective endocarditis (IE) of guideline recommendations to restrict indications for antibiotic prophylaxis. We conducted a systematic review according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guideline. PubMed and EMBASE databases were searched for articles published between 2007 and 2015 using mesh terms relevant to the research question. Included were English language articles… Expand
Infective endocarditis prophylaxis: a review
TLDR
Controversial guidelines for prophylaxis against infective endocarditis have changed significantly due to a lack of evidence for its efficacy and increasing concerns about safety and antibiotic resistance but conflicting data exists on the impact of these changes on the trends of IE hospitalisation and clinical outcomes. Expand
Infective endocarditis in children: an update
TLDR
The impact of the updated 2015 American Heart Association and European Society of Cardiology guidelines on management as well as the significance of the new predisposing factors, diagnostic and treatment options, and the effect of the 2007–2008 change in prophylaxis recommendations are reviewed. Expand
Surgery for acute infective endocarditis: epidemiological data from a Spanish nationwide hospital-based registry.
TLDR
Surgical treatment in IE has trended upwards in Spain during the last 2 decades and patients are getting older and more frequently experience organ dysfunction. Expand
Antibiotic prophylaxis for infective endocarditis: some rarely addressed issues
TLDR
Although quite consistent indications on antibiotic prophylaxis for infective endocarditis (IE) have been reported internationally, several common dental practice issues are still not clear: which dental procedures require antibiotic proPHylaxis and how can dentists identify high-risk conditions for IE. Expand
Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part II: infective endocarditis, pulmonary hypertension, pulmonary arterial hypertension and aortopathy.
TLDR
The present publication emphasizes current data on IE, pulmonary and pulmonary arterial hypertension and aortopathy in ACHD and underlines the deep need of an experienced follow-up care by specialized and/or certified physicians or centers, as treatment regimens from acquired heart disease can not be necessarily transmitted to CHD. Expand
Is the Freedom SOLO Stentless Bioprosthesis a Useful Tool for Patients with Aortic Endocarditis and Aortic Annular Destruction?
TLDR
Although in this group of complex patients, early mortality remains considerably high, late survival outcomes are comparable to the more technically demanding homografts and conventional stentless bioprostheses, with low rates of endocarditis recurrence. Expand
Medizinische Versorgung von Erwachsenen mit angeborenen Herzfehlern
TLDR
According to the results of the medical care of ACHD (MC-ACHD) study, A CHD centers and specialists in Germany are insufficiently perceived despite increased complication rates and the great need for specialist guidance. Expand
Sind Erwachsene mit angeborenen Herzfehlern ausreichend versorgt?
TLDR
The number of adults with congenital heart disease (CHD) in Germany is currently estimated to be approximately 280,000, which is higher than the number of children with CHD, and nearly all grown-ups with congenitals heart defects (GUCH) have residual complaints and sequelae that require a life-long follow-up. Expand
Cutaneous Vasculitis and Generalized Lymphadenopathy Associated with Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli Endocarditis: A Rare Case Report
TLDR
A rare case of blood culture-negative infective endocarditis due to extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli manifest with cutaneous vasculitis and generalized lymphadenopathy is presented, highlighting its diagnostic challenge and management. Expand
...
1
2
...

References

SHOWING 1-10 OF 36 REFERENCES
Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey.
  • C. Selton-Suty, M. Célard, +11 authors B. Hoen
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2012
TLDR
S. aureus became both the leading cause and the most important prognostic factor of IE, and healthcare-associated IE appeared as a major subgroup of the disease. Expand
Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys.
TLDR
Scaling down antibiotic prophylaxis indications was not associated with an increased incidence of oral streptococcal IE, and a focus on avoidance of S. aureus bacteremia in all patients, including those with no previously known valve disease, will be required to improve IE prevention. Expand
Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands
TLDR
There has been a steady increase in the IE incidence between 2005 and 2011, and after the introduction of the 2009 ESC guidelines, the incidence increased more than expected from previous historical trends. Expand
Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011.
TLDR
Results show that IE incidence has increased in the United States over the past decade, and there has been a significant rise in the incidence of Streptococcus IE since the 2007 guideline revisions. Expand
NICE guidance on antibiotic prophylaxis to prevent infective endocarditis: a survey of clinicians' attitudes.
TLDR
Many patients perceived to be at high risk of IE are still receiving AP in conflict with current NICE guidance, and the majority of respondents feel that more evidence is required, preferably in the form of a randomized controlled trial. Expand
Prophylaxis for infective endocarditis: let's end the debate
TLDR
There is a small but significant increase in the incidence of infective endocarditis since 2008, of 0·11 cases per 10 million people per month (95% CI 0·05–0·16) above the projected historical trend, which by March, 2013 would account for an excess of 35 cases per month. Expand
Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study
TLDR
Despite a 78.6% reduction in prescribing of antibiotic prophylaxis after the introduction of the NICE guideline, this study excluded any large increase in the incidence of cases of or deaths from infective endocarditis in the two years after the guideline. Expand
Infective Endocarditis Hospitalizations Before and After the 2007 American Heart Association Prophylaxis Guidelines.
TLDR
The rate of IE hospitalizations increased in Canada before and after the publication of the 2007 AHA guidelines, with no significant change in slope after 2007. Expand
Trends in endocarditis hospitalizations at US children's hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines.
TLDR
No evidence is found that release of new antibiotic prophylaxis guidelines was associated with a significant change in IE admissions across 37 US children's hospitals during this period. Expand
Epidemiology of bacterial endocarditis in The Netherlands. II. Antecedent procedures and use of prophylaxis.
TLDR
The results indicate that medical and dental procedures cause only a small fraction of endocarditis, and the majority of patients develop the disease along other routes. Expand
...
1
2
3
4
...